secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2026-04-01T23:59:59+00:00
Accession:  0001193125-26-137984
Event type: debt
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra repays $15M Hercules loan, terminates credit facility
-------------------------------------------------------------

- Paid off $15M outstanding borrowings and terminated all commitments under Hercules Credit Facility on April 1, 2026.
- Credit facility had maturity date of April 1, 2026; termination follows previously disclosed terms.
- Cash, equivalents, and marketable securities as of Dec 31, 2025 expected to support operations into 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526137984/0001193125-26-137984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526137984/aldx-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-137984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer